The Future of Metabolomic Profiling in Population-Based Research: Opportunities and Challenges

Metabolomics is an approach that employs technologies to measure small molecule metabolites in biological samples, thus providing epidemiologists and other investigators with a means to discover biomarkers of disease risk, diagnosis, and prognosis. To advance the field of metabolomics, the National Institutes of Health (NIH) is investing $65 million through the NIH Common Fund’s Metabolomics Program, which will support comprehensive metabolomics resource cores, training in metabolomics, metabolomics technology development, metabolomics reference standards synthesis, and data sharing and international collaboration. While this infrastructure will be essential, there remain several challenges to broad implementation of metabolomics in population-based studies. To facilitate the use of metabolomics in population-based studies, the NIH-sponsored ‘Think Tank on the Use of Metabolomics in Population-Based Research’ was held to discuss the current opportunities and challenges of the field and identify potential solutions and/or strategies to address challenges. Insights and conclusions gained from the Think Tank are summarized here.

[1]  M. Shen,et al.  Diagnostics: The prostate-cancer metabolome , 2009, Nature.

[2]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[3]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[4]  P. Elliott,et al.  Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. , 2006, Analytical chemistry.

[5]  F Berrino,et al.  Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer , 2011, British Journal of Cancer.

[6]  Marc Chadeau-Hyam,et al.  Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. , 2010, Journal of proteome research.

[7]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[8]  Jeremiah Stamler,et al.  A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: the INTERMAP Study. , 2012, American journal of epidemiology.

[9]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[10]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[11]  Wei Zheng,et al.  Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Marc Chadeau-Hyam,et al.  Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. , 2010, Journal of proteome research.

[13]  D. Wishart,et al.  The food metabolome: a window over dietary exposure. , 2014, The American journal of clinical nutrition.

[14]  Emmanuel Hatzakis,et al.  Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. , 2014, Cancer research.

[15]  C. Slupsky,et al.  Metabolomics and detection of colorectal cancer in humans: a systematic review. , 2010, Future oncology.

[16]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[17]  Christoph Steinbeck,et al.  MetaboLights—an open-access general-purpose repository for metabolomics studies and associated meta-data , 2012, Nucleic Acids Res..

[18]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[19]  Tao Zhang,et al.  Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. , 2013, Journal of proteome research.

[20]  Catherine A Rimmer,et al.  Development of a Standard Reference Material for metabolomics research. , 2013, Analytical chemistry.

[21]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[22]  I. Bertini,et al.  Metabolomics: available results, current research projects in breast cancer, and future applications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Jolanta Lissowska,et al.  Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. , 2012, The Journal of clinical endocrinology and metabolism.

[24]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.